KR20050110148A - 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 - Google Patents
싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 Download PDFInfo
- Publication number
- KR20050110148A KR20050110148A KR1020040035047A KR20040035047A KR20050110148A KR 20050110148 A KR20050110148 A KR 20050110148A KR 1020040035047 A KR1020040035047 A KR 1020040035047A KR 20040035047 A KR20040035047 A KR 20040035047A KR 20050110148 A KR20050110148 A KR 20050110148A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- skin
- effect
- present
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- 240000000604 Lespedeza bicolor Species 0.000 title description 2
- 235000016677 Lespedeza bicolor Nutrition 0.000 title description 2
- 244000061457 Solanum nigrum Species 0.000 title description 2
- 235000002594 Solanum nigrum Nutrition 0.000 title description 2
- 230000002087 whitening effect Effects 0.000 claims abstract description 23
- 239000006210 lotion Substances 0.000 claims abstract description 15
- 235000003840 Amygdalus nana Nutrition 0.000 claims abstract description 14
- 235000011432 Prunus Nutrition 0.000 claims abstract description 14
- 206010040880 Skin irritation Diseases 0.000 claims abstract description 14
- 235000014774 prunus Nutrition 0.000 claims abstract description 14
- 230000036556 skin irritation Effects 0.000 claims abstract description 14
- 231100000475 skin irritation Toxicity 0.000 claims abstract description 14
- 239000006071 cream Substances 0.000 claims abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 13
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 9
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 240000001548 Camellia japonica Species 0.000 claims description 3
- 235000018597 common camellia Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 241000195955 Equisetum hyemale Species 0.000 claims description 2
- 244000183278 Nephelium litchi Species 0.000 claims description 2
- 235000015742 Nephelium litchi Nutrition 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 244000296825 Amygdalus nana Species 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000007762 w/o emulsion Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 43
- 210000003491 skin Anatomy 0.000 abstract description 30
- 230000008099 melanin synthesis Effects 0.000 abstract description 18
- 102000004190 Enzymes Human genes 0.000 abstract description 13
- 108090000790 Enzymes Proteins 0.000 abstract description 13
- 241000220299 Prunus Species 0.000 abstract description 13
- -1 pack Substances 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 12
- 230000005764 inhibitory process Effects 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 230000004054 inflammatory process Effects 0.000 abstract description 8
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 230000030833 cell death Effects 0.000 abstract description 5
- 206010014970 Ephelides Diseases 0.000 abstract description 4
- 208000003351 Melanosis Diseases 0.000 abstract description 4
- 210000004927 skin cell Anatomy 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 241001415939 Corvus Species 0.000 abstract description 3
- 241000392950 Prunus japonica Species 0.000 abstract description 3
- 235000013999 Prunus japonica Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 239000000419 plant extract Substances 0.000 abstract description 3
- XSKZXGDFSCCXQX-UHFFFAOYSA-N thiencarbazone-methyl Chemical compound COC(=O)C1=CSC(C)=C1S(=O)(=O)NC(=O)N1C(=O)N(C)C(OC)=N1 XSKZXGDFSCCXQX-UHFFFAOYSA-N 0.000 abstract description 3
- 240000000724 Berberis vulgaris Species 0.000 abstract description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 230000000116 mitigating effect Effects 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 34
- 230000002401 inhibitory effect Effects 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 21
- 239000000243 solution Substances 0.000 description 14
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 12
- 102000004127 Cytokines Human genes 0.000 description 10
- 108090000695 Cytokines Proteins 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 102000004889 Interleukin-6 Human genes 0.000 description 8
- 108090001005 Interleukin-6 Proteins 0.000 description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 229940100601 interleukin-6 Drugs 0.000 description 8
- 210000002510 keratinocyte Anatomy 0.000 description 8
- 210000002752 melanocyte Anatomy 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 244000184734 Pyrus japonica Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000003061 melanogenesis Effects 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 102000004125 Interleukin-1alpha Human genes 0.000 description 4
- 108010082786 Interleukin-1alpha Proteins 0.000 description 4
- 235000017848 Rubus fruticosus Nutrition 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 235000021029 blackberry Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 229940069445 licorice extract Drugs 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108010003272 Hyaluronate lyase Proteins 0.000 description 3
- 102000001974 Hyaluronidases Human genes 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 240000002299 Symphytum officinale Species 0.000 description 3
- 235000005865 Symphytum officinale Nutrition 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 229960002773 hyaluronidase Drugs 0.000 description 3
- 210000002780 melanosome Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102400000686 Endothelin-1 Human genes 0.000 description 2
- 101800004490 Endothelin-1 Proteins 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 229920001007 Nylon 4 Polymers 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 240000001987 Pyrus communis Species 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000019714 Triticale Nutrition 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000005754 cellular signaling Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 241000228158 x Triticosecale Species 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001365101 Corica Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000510678 Falcaria vulgaris Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 240000002878 Prunus cerasus Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000011539 homogenization buffer Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003101 melanogenic effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K93/00—Floats for angling, with or without signalling devices
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K95/00—Sinkers for angling
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cosmetics (AREA)
Abstract
Description
시료명 | 처리농도(%) | 멜라닌 합성 저해효과(IC50) |
싸리나무 추출물(실시예 1) | 0.1 | 0.1% |
까마중 추출물(실시예 2) | 0.1 | 0.15% |
하이드로퀴논 | 0.1 | 0.03% |
알부틴 | 0.1 | 0.2% |
상백피 추출물 | 0.1 | 5% |
유용성 감초 추출물 | 0.1 | 0.03% |
시료 | 싸이토카인 합성 저해효과(IC50) | |
인터루킨-1α | 인터루킨-6 | |
알부틴 | 0 | 0 |
싸리나무 추출물 | 0.01% | 0.008% |
까마중 추출물 | 0.005% | 0.001% |
시료명 | 멜라닌 합성저해효과(IC50) |
싸리나무 추출물 | 0.1% |
까마중 추출물 | 0.08% |
컴프리추출물 | 0.22% |
시소 추출물 | 0.58% |
유용성 감초추출믈 | 0.08% |
삼백초 추출물 | 0.3% |
시료 | 섬유아세포 생존율(%) |
0.01% SLS | 25 |
0.01% SLS + 0.01% 싸리나무 추출물 | 57 |
0.01% SLS + 0.01% 까마중 추출물 | 54 |
원료 | 실시예 7 | 실시예 8 | 비교예 1 | |
가 | 스테아릴 알콜 | 8 | 8 | 8 |
스테아린산 | 2 | 2 | 2 | |
스테아린산 콜레스테롤 | 2 | 2 | 2 | |
스쿠알란 | 4 | 4 | 4 | |
2-옥틸도데실알콜 | 6 | 6 | 6 | |
폴리옥시에틸렌(25몰부가)알콜에스테르 | 3 | 3 | 3 | |
글리세릴모노스테아린산아스테르 | 2 | 2 | 2 | |
나 | 싸리나무 추출물(실시예1) | 1 | - | - |
까마중 추출물(실시예2) | - | 1 | - | |
프로필렌글리콜 | 5 | 5 | 5 | |
적량 | 적량 | 적량 | 적량 |
피부색의 밝기 변화( L) | 숙련자의 객관적 평가 | 피검자의 주관적 평가 | |||||||
실시예7 | 실시예8 | 비교예1 | 실시예7 | 실시예8 | 비교예1 | 실시예7 | 실시예8 | 비교예1 | |
평균값 | 5.32 | 4.82 | 2.03 | 2.9 | 2.3 | 1.9 | 2.7 | 2.2 | 1.7 |
Claims (8)
- 싸리나무 추출물, 까마중 추출물 및 이들의 혼합물로 이루어지는 군에서 선택된 성분을 주요 활성성분으로 함유하는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,상기 싸리나무 추출물 또는 까마중 추출물을 조성물 전체에 대하여 동결건조중량기준 0.001 내지 30.0 중량% 함유하는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,상기 싸리나무 추출물 및 까마중 추출물의 혼합물은 조성물 전체에 대하여 동결건조중량기준 0.001 내지 30.0 중량% 함유하는 것을 특징으로 하는 화장료 조성물.
- 제1항 내지 제3항 중 어느하나의 항에 있어서,추출용매로 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄,헥산 및 그의 혼합물로부터 선택된 것을 사용하는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,피부 미백용으로 사용되는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,항염증용으로 사용되는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,피부 자극 완화용으로 사용되는 것을 특징으로 하는 화장료 조성물.
- 제1항에 있어서,화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W) 또는 유중수(W/O) 에멀전, 연고의 제형 중에서 선택되는 것을 특징으로 하는 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040035047A KR100563547B1 (ko) | 2004-05-18 | 2004-05-18 | 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040035047A KR100563547B1 (ko) | 2004-05-18 | 2004-05-18 | 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050110148A true KR20050110148A (ko) | 2005-11-23 |
KR100563547B1 KR100563547B1 (ko) | 2006-03-27 |
Family
ID=37285712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040035047A KR100563547B1 (ko) | 2004-05-18 | 2004-05-18 | 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100563547B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100702891B1 (ko) * | 2005-08-17 | 2007-04-03 | 대구한의대학교산학협력단 | 항산화 활성을 갖는 싸리 추출물을 함유하는 화장료조성물 |
KR101407061B1 (ko) * | 2012-10-23 | 2014-06-12 | 주식회사 엑티브온 | 타이로시네이즈 저해 활성을 가지는 조성물 |
KR20180109265A (ko) * | 2017-03-27 | 2018-10-08 | (주)자작나눔 | 싸리나무추출물을 주요성분으로 하는 액상거품 세안제 제조방법 및 그 조성물 |
KR101976572B1 (ko) * | 2018-11-30 | 2019-05-09 | 충청남도 | 비수리 추출물을 포함하는 천연 방부제 조성물 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100847478B1 (ko) | 2007-04-13 | 2008-07-21 | 에이비씨나노텍 주식회사 | 금 또는 은 나노입자 및 까마중 추출물의 중합체를유효성분으로 함유한 기능성 비누 조성물 및 이의 제조방법 |
KR101161346B1 (ko) | 2010-01-29 | 2012-07-02 | 계명대학교 산학협력단 | 항산화, 항염증 및 미백에 유효한 싸리나무 성분의 추출방법 |
-
2004
- 2004-05-18 KR KR1020040035047A patent/KR100563547B1/ko active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100702891B1 (ko) * | 2005-08-17 | 2007-04-03 | 대구한의대학교산학협력단 | 항산화 활성을 갖는 싸리 추출물을 함유하는 화장료조성물 |
KR101407061B1 (ko) * | 2012-10-23 | 2014-06-12 | 주식회사 엑티브온 | 타이로시네이즈 저해 활성을 가지는 조성물 |
KR20180109265A (ko) * | 2017-03-27 | 2018-10-08 | (주)자작나눔 | 싸리나무추출물을 주요성분으로 하는 액상거품 세안제 제조방법 및 그 조성물 |
KR101976572B1 (ko) * | 2018-11-30 | 2019-05-09 | 충청남도 | 비수리 추출물을 포함하는 천연 방부제 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR100563547B1 (ko) | 2006-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101832288B1 (ko) | 용암해수와 탄산수, 또는 암반수를 이용한 녹차 추출물의 제조 방법 및 이를 함유하는 기능성 화장료 조성물 | |
KR100732564B1 (ko) | 진피 추출물을 주요 활성 성분으로 함유하는 피부외용제조성물 | |
KR101026879B1 (ko) | 피부주름개선용 화장료 조성물의 제조방법 | |
KR101078888B1 (ko) | 조직배양한 에키네시아 부정근 추출물을 포함하는 화장료 조성물 및 이의 제조 방법 | |
KR20170076147A (ko) | 피부 개선용 조성물 | |
KR100563547B1 (ko) | 싸리나무 및/또는 까마중 추출물을 주요 활성성분으로함유하는 화장료 조성물 | |
KR100860605B1 (ko) | 스트로브 잣나무피 추출물 및 니아신아마이드를 함유하는 화장료 조성물 | |
KR101027113B1 (ko) | 해송의 송기 추출물을 함유하는 화장료 조성물의 제조방법 | |
KR20090097550A (ko) | 슈잔드린 및 이 추출물을 유효성분으로 함유하는 화장료조성물 | |
KR101208013B1 (ko) | 참바늘버섯 균사체 추출물을 함유하는 피부 외용제 조성물 | |
KR101909578B1 (ko) | 제주양지꽃 추출물을 함유하는 피부 외용제 조성물 | |
KR20100018139A (ko) | 돌나물 추출물 및 리포익산-peg 콘쥬게이트를 함유하는피부외용제 조성물 | |
KR100525994B1 (ko) | 복방 생약 추출물을 함유하는 화장료 조성물 | |
KR101939112B1 (ko) | 진세노사이드 f1을 함유하는 피부 외용제 조성물 | |
KR101317433B1 (ko) | 지구자, 길경, 밀싹 및 세이지 추출물을 함유하는 미백 화장용 조성물 | |
KR101909533B1 (ko) | 진세노사이드 f1을 함유하는 피부 외용제 조성물 | |
KR100552269B1 (ko) | 금등화 추출물 또는 비자 추출물로부터 선택된 1종 이상을 주요 활성성분으로 함유하는 피부외용 화장료 조성물 | |
KR20030086933A (ko) | 잘피 추출물을 주요 활성성분으로 하는 화장료 조성물 | |
KR20080029037A (ko) | 먼나무 추출물을 유효성분으로 포함하는 피부 미백용화장료 조성물 | |
KR100935329B1 (ko) | 엘라직산을 유효성분으로 포함하는 피부 미백활성을 갖는 장딸기의 열매 추출물 | |
KR101274606B1 (ko) | 초고압 대추 추출물을 함유하는 화장료 조성물 | |
KR100983526B1 (ko) | 백수 추출물을 함유하는 화장료 조성물 | |
KR100961761B1 (ko) | 산당화 추출물을 함유하는 화장료 조성물 | |
KR101844980B1 (ko) | 제주산버들 추출물을 함유하는 피부 외용제 조성물 | |
KR20110062159A (ko) | 장뇌삼 캘러스 추출물을 함유하는 피부 미백용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130311 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140314 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150316 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160316 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170316 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180306 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190221 Year of fee payment: 14 |